Menta Capital’s Zimmer Biomet ZBH Stock Holding History

Menta Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,603	Closed	-$695K	–	604
2019 Q1	$695K	Buy	+5,603	New	+$637K	0.3%	111
2018 Q3	–	Sell	-7,704	Closed	-$834K	–	736
2018 Q2	$834K	Buy	+7,704	New	+$838K	0.19%	189

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Menta Capital's ZBH Position: Q2 2019 in Review

Menta Capital sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 5,603 shares — an estimated $695K sold.

Menta Capital first reported a position in ZBH in Q2 2018 and held it in 2 quarters. The position peaked at $834K in Q2 2018. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

Menta Capital reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
Menta Capital sold 5,603 Zimmer Biomet shares in Q2 2019, an estimated $695K.
Menta Capital first reported a position in Zimmer Biomet in Q2 2018 and held it in 2 quarters.
Menta Capital's Zimmer Biomet position peaked at $834K in Q2 2018.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.